Braveheart wins first advisory role

Braveheart Financial Services, the boutique investment bank sold to Evercore for $50m (€39.2m) the day before it opened in August, has won its first mandate.

Braveheart is working alongside Lazard as financial adviser to UCB on the Belgian pharmaceutical group's recommended €4.4bn ($5.6bn) bid for German rival Schwarz Pharma, which was announced on Monday. Rothschild is working for the German company.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump